BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20699718)

  • 1. Use of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseases.
    Liu X; Ye W; Watson P; Tepper P
    J Nerv Ment Dis; 2010 Aug; 198(8):544-50. PubMed ID: 20699718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of benzodiazepine use in individuals with insomnia.
    Morin CM; Bélanger L; Bernier F
    Sleep Med; 2004 Sep; 5(5):457-62. PubMed ID: 15341890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Hypnotic' prescription patterns in a large managed-care population.
    Roehrs T; Roth T
    Sleep Med; 2004 Sep; 5(5):463-6. PubMed ID: 15341891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study.
    Fang SY; Chen CY; Chang IS; Wu EC; Chang CM; Lin KM
    Drug Alcohol Depend; 2009 Sep; 104(1-2):140-6. PubMed ID: 19515515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD).
    Demyttenaere K; Bonnewyn A; Bruffaerts R; De Girolamo G; Gasquet I; Kovess V; Haro JM; Alonso J
    J Affect Disord; 2008 Sep; 110(1-2):84-93. PubMed ID: 18329721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population.
    Neutel CI; Skurtveit S; Berg C
    Sleep Med; 2012 Aug; 13(7):893-7. PubMed ID: 22704401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled comparison of the characteristics of long-term benzodiazepine users in general practice.
    Simpson RJ; Power KG; Wallace LA; Butcher MH; Swanson V; Simpson EC
    Br J Gen Pract; 1990 Jan; 40(330):22-6. PubMed ID: 1969288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anxiety disorders in the Finnish general population.
    Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
    J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits and risks of benzodiazepines. A current analysis of facts].
    Allgulander C; Msghina M
    Lakartidningen; 2011 Oct 12-18; 108(41):2025-9. PubMed ID: 22111250
    [No Abstract]   [Full Text] [Related]  

  • 12. Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study.
    Osler M; Jørgensen MB
    Am J Psychiatry; 2020 Jun; 177(6):497-505. PubMed ID: 32252539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.
    Lagnaoui R; Moore N; Longy-Boursier M; Baumevieille M; Bégaud B
    Pharmacoepidemiol Drug Saf; 2001; 10(6):531-5. PubMed ID: 11828836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription and intake patterns in long-term and ultra-long-term benzodiazepine treatment in primary care practice.
    Geiselmann B; Linden M
    Pharmacopsychiatry; 1991 Mar; 24(2):55-61. PubMed ID: 1677204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption among Canadians taking benzodiazepines and related drugs.
    Veldhuizen S; Wade TJ; Cairney J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):203-10. PubMed ID: 19115421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytics and sedatives and risk of fractures: effects of half-life.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Jan; 82(1):34-43. PubMed ID: 18175030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain and depression in older people: comorbidity and patterns of help seeking.
    Bonnewyn A; Katona C; Bruffaerts R; Haro JM; de Graaf R; Alonso J; Demyttenaere K
    J Affect Disord; 2009 Oct; 117(3):193-6. PubMed ID: 19217167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of benzodiazepines as anxiolytics in neonates: are we there yet?
    Nelson MA; Bradshaw WT
    Adv Neonatal Care; 2014 Apr; 14(2):78-85; quiz 86-7. PubMed ID: 24675625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations.
    Bocquier A; Bezzou K; Nauleau S; Verger P
    Fundam Clin Pharmacol; 2008 Jun; 22(3):323-33. PubMed ID: 18485151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benzodiazepine: long term use and addiction].
    Holzbach R
    Fortschr Neurol Psychiatr; 2010 Jul; 78(7):425-31, quiz 432-4. PubMed ID: 20411482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.